Orthogon Biosciences Targets Viral Capsid Protein VP1 for Next-Generation Antiviral Therapy Orthogon Biosciences is advancing a novel antiviral strategy that directly targets the viral capsid protein VP1, a critical component …
Tag:
antivirals
-
-
Understanding Covifor: Hetero Healthcare’s Generic Remdesivir for COVID-19 The fight against COVID-19 required rapid pharmaceutical innovation and the scaling of critical treatments. One of the most significant milestones in this …
-
Here’s a breakdown of the information provided in the text, organized into key topics: 1.High-Risk Groups for Flu Complications: * age: 65 years or older * chronic Medical Conditions: * …